DOI QR코드

DOI QR Code

Characterization of β-Secretase Inhibitory Peptide Purified from Blackfin flounder (Glyptocephalus stelleri) Protein Hydrolysate

  • Lee, Jung Kwon (Department of Marine Biotechnology, Gangneung-Wonju National University) ;
  • Kim, Sung Rae (Department of Marine Biotechnology, Gangneung-Wonju National University) ;
  • Byun, Hee-Guk (Department of Marine Biotechnology, Gangneung-Wonju National University)
  • Received : 2018.01.12
  • Accepted : 2018.02.06
  • Published : 2018.06.30

Abstract

The objective of this study was to purify and characterize the ${\beta}-secretase$ inhibitor from enzymatic hydrolysates of blackfin flounder muscle, for development of a novel anti-dementia agent that may be used in the drug or functional food industries. ${\beta}-secretase$ inhibitory peptide was purified from various enzymatic hydrolysates of blackfin flounder muscle. Among six enzymatic hydrolysates, the Alcalase hydrolysate revealed highest ${\beta}-secretase$ inhibitory activity. Consecutive purification of the blackfin flounder muscle hydrolysate using Sephadex G-25 column chromatography and octadecylsilane C18 reversed phase HPLC techniques were used to isolate a potent ${\beta}-secretase$ inhibitory peptide composed of 5 amino acids, Leu-Thr-Gln-Asp-Trp (MW: 526.7 Da). The $IC_{50}$ value of purified ${\beta}-secretase$ inhibitory peptide was $126.93{\mu}M$. Results of this study suggest that peptides derived from blackfin flounder muscle may be beneficial as anti-dementia compounds in functional foods or as pharmaceuticals.

Keywords

References

  1. The Ministry of Health Wefare and Family Affairs. 2009. Nationwide study on the prevalence of dementia in Korean elders. Seoul.
  2. Querfurth, H.W., LaFerla, F.M. 2010. Alzheimer's disease. New Engl. J. Med. 362, 329-344. https://doi.org/10.1056/NEJMra0909142
  3. Yiannopoulou, K.G., Papageorgiou, S.G. 2013. Current and future treatments for Alzheimer's disease. Ther. Adv. Neurol. Dis. 6, 19-33. https://doi.org/10.1177/1756285612461679
  4. Cole, S.L., Vassar, R. 2007. The Alzheimer's disease ${\beta}$-secretase enzyme, BACE1. Mol. Neurodegener. 2, 22. https://doi.org/10.1186/1750-1326-2-22
  5. Dash, C.K., Kulkarni, A., Dunn, B., Rao, M. 2003. Aspartic peptidase inhibitors: implications in drug development. Crit. Rev. Biochem. Mol. Biol. 38, 89-119. https://doi.org/10.1080/713609213
  6. Dorrel, S. 2000. Untangling Alzheimer's disease with ${\beta}$-secretase inhibitors. Drug Discov. Today. 5, 316-317. https://doi.org/10.1016/S1359-6446(00)01531-2
  7. Ghosh, A.K., Shin, D., Koelsch, G., Lin, X., Ermolieff, J., Tang, J. 2000. Design of potent inhibitors for human brain memapsin 2 (${\beta}$-secretase). J. Am. Chem. Soc. 122, 3522-3523. https://doi.org/10.1021/ja000300g
  8. Turner, R.T., Koelsch, G., Hong, L., Castanheira, P., Ermolieff, J., Ghosh, A.K. 2001. Subsite specificity of memapsin 2 (${\beta}$-secretase): implications for inhibitor design. Biochem. 40, 10001-10006. https://doi.org/10.1021/bi015546s
  9. Garino, C., Pietrancosta, N., Laras, Y., Moret, V., Rolland, A., Quelever, G. 2006. BACE1 inhibitory activities of new substituted phenylpiperazine coupled to various heterocycles: chromene, coumarin and quinoline. Bioorg. Med. Chem. Lett. 16, 1995-1999. https://doi.org/10.1016/j.bmcl.2005.12.064
  10. Kimura, T., Hamada, Y., Stochaj, M., Ikari, H., Nagamine, A., Abdel-Rahman, H. 2006. Design and synthesis of potent ${\beta}$-secretase (BACE1) inhibitors with carboxylic acid bioisosteres. Bioorg. Med. Chem. Lett. 16, 2380-2386. https://doi.org/10.1016/j.bmcl.2006.01.108
  11. NFRDI. Commercial Fishes of the Coastal and Offshore Waters in Korea. 2004. Report of the National Fisheries Research and Development Institute, 2nd edition. Hangul Press, Busan, Korea.
  12. Lee, J.M. 2008. Age and growth of Korean flounder (Glyptocephalus stelleri) in the East Sea of Korea. MS Thesis, Pukyong National University, Busan, Korea.
  13. Cha, H.K., Kwon, H.C., Lee, S.I., Yang, J.H., Chang, D.S., Chun, Y.Y. 2008. Maturity and spawning of Korean flounder, Glytocephalus stelleri (Schmidt) in the East Sea of Korea. Korean J. Ichthyol. 20, 263-271.
  14. Mohr, V. 1980. Enzymes technology in the meat and fish industries. Process Biochem. 80, 18-23.
  15. Shahidi, F., Han, X.Q., Synowiecki, J. 1995. Production and characteristics of protein hydrolysates from capelin (Mallotus villosus). Food Chem. 53, 258-293.
  16. Diniz, F.M., Martin, A.M. 1998. Influence of process variables on the hydrolysis of shark muscle protein. Food Sci. Technol. Int. 4, 91-98. https://doi.org/10.1177/108201329800400203
  17. Raghunath, M.R. 1993. Enzymatic protein hydrolysate from tuna canning wastes: standardization of hydrolysis parameters. Fish Technol. 30, 40-45.
  18. Kitts, D.D., Weiler, K. 2003. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr. Pharm. Des. 9, 1309-1323. https://doi.org/10.2174/1381612033454883
  19. Kovacs-Nolan, J., Phillips, M., Mine, Y. 2005. Advances in the value of eggs and egg components for human health. J. Agric. Food Chem. 53, 8421-8431. https://doi.org/10.1021/jf050964f
  20. Meisel, H. 1997. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers. 43, 119-128. https://doi.org/10.1002/(SICI)1097-0282(1997)43:2<119::AID-BIP4>3.0.CO;2-Y
  21. Korhonen, H., Pihlanto, A. 2006. Bioactive peptides: production and functionality. Int. Dairy J. 16, 945-960. https://doi.org/10.1016/j.idairyj.2005.10.012
  22. Johnston, J.A., Liu, W.W., Coulson, D.T.R., Todd, S., Murphy, S., Brennan, S. 2008. Platelet ${\beta}$-secretase activity is increased in Alzheimer' disease. Neurobiol. Agin. 29, 661-668. https://doi.org/10.1016/j.neurobiolaging.2006.11.003
  23. Zhu, K.X., Zhou, H.M., Qian, H.F. 2006. Antioxidant and free radical-scavenging activities of wheat germ prote in hydrolysates (WGPH) prepared with Alcalase. Process Biochem. 41, 1296-1302. https://doi.org/10.1016/j.procbio.2005.12.029
  24. Lee, J.K., Hong, S., Jeon, J.K., Kim, S.K., and Byun, H.G. 2009. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis. Bioresour. Technol. 100, 5255-5259. https://doi.org/10.1016/j.biortech.2009.05.057
  25. Lu, J., Ren, D.F., Xue, Y.L., Sawano, Y., Miyakawa, T., Tanokura, M. 2010. Isolation of an antihypertensive peptide from Alcalase digest of Spirulina platensis. J. Agric. Food Chem. 58, 7166-7171. https://doi.org/10.1021/jf100193f
  26. Ahn, C.B., Jeon, Y.J., Kim, Y.T., Je, J.Y. 2012. Angiotens in I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis. Process Biochem. 47, 2240-2245. https://doi.org/10.1016/j.procbio.2012.08.019
  27. Zhong, F., Zhang, X., Ma, J., Shoemaker, C. 2007. Fractionation and identification of a novel hypocholesterolemic peptide derived from soy protein Alcalase hydrolysates. Food Res. Int. 40, 756-762. https://doi.org/10.1016/j.foodres.2007.01.005
  28. Je, J.Y., Park, P.J., Byun, H.G., Jung, W.K., Kim, S.K. 2005. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis. Bioresour. Technol. 96, 1624-1629. https://doi.org/10.1016/j.biortech.2005.01.001
  29. Lee, D.H., Lee, D.H., Lee, J.S. 2007. Characterization of a new antidementia ${\beta}$-secretase inhibitory peptide from Saccharomyces cerevisiae. Enzyme Microb. Technol. 42, 83-88. https://doi.org/10.1016/j.enzmictec.2007.08.003
  30. Lee, J.K., Li-Chan, E.C.Y., Byun, H.G. 2015. Characteriz ation of ${\beta}$-secretase inhibitory peptide purified from skate skin protein hydrolysate. Eur. Food Res. Technol. 240, 129-136. https://doi.org/10.1007/s00217-014-2314-9
  31. Li-Chan, E.C.Y., Cheung, I.W.Y., Byun, H.G. 2016. Shrimp (Pandalopsis dispar) waste hydrolysate as a source of novel ${\beta}$-secretase inhibitors. Fish Aquat. Sci. 19, 11. https://doi.org/10.1186/s41240-016-0008-x
  32. Turner, R.T., Koelsch, G., Hong, L., Castanheira, P., Ghosh, A., Tang, J. 2001. Subsite specificity of memapsin 2 (${\beta}$-Secretase): implications for inhibitor design. Biochemistry. 40, 10001-10006. https://doi.org/10.1021/bi015546s
  33. Tung, J.S., Davis, D.L., Anderson, J.P., Walker, D.E., Mamo, S., Jewett, N., Hom, R.K., Sinha, S., Thorsett, E.D., John, V. 2002. Design of substrate-based inhibitors of human ${\beta}$-secretase. J. Med. Chem. 45, 259-262. https://doi.org/10.1021/jm0155695

Cited by

  1. Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities vol.19, pp.8, 2021, https://doi.org/10.3390/md19080410